Alembic Pharma gets USFDA nod for bipolar depression drug

The approved product is therapeutically equivalent to the reference listed drug product (RLD) Latuda tablets of Sunovion Pharmaceuticals Inc.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hobAo3
via IFTTT

0 comments:

Post a Comment